Recently, FAK PROTAC (Proteolysis Targeting Chimeric Molecule) degrader has been developed to block both pathways and showed greatly improved activity to inhibit cancer cell invasion as compared to its parent VS6063 kinase inhibitor (12). Here, PTK2 is linked to cancer.